Acorah Software Products - Accounts Production19.2.450falsetruefalsetrueNo description of principal activity1 December 202430 November 202530 November 202515317442Miss TALAN KARIMiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure153174422024-11-30153174422025-11-30153174422024-12-012025-11-3015317442frs-core:CurrentFinancialInstruments2025-11-3015317442frs-bus:PrivateLimitedCompanyLtd2024-12-012025-11-3015317442frs-bus:FilletedAccounts2024-12-012025-11-3015317442frs-bus:Micro-entities2024-12-012025-11-3015317442frs-bus:AuditExempt-NoAccountantsReport2024-12-012025-11-3015317442frs-bus:Director12024-12-012025-11-30
Registered number: 15317442
Karim Pharma Limited
Unaudited Financial Statements
For The Year Ended 30 November 2025
UK TAX ACCOUNTANTS
2 Victor Street
Bradford
West Yorkshire
BD9 4RB
Karim Pharma Limited
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 15317442
2025
£
Current assets
17,287
Creditors: Amounts Falling Due Within One Year
(8,727)
NET CURRENT ASSETS
8,560
TOTAL ASSETS LESS CURRENT LIABILITIES
8,560
Accruals and deferred income
(550)
NET ASSETS
8,010
CAPITAL AND RESERVES
8,010
Notes
1.General Information
Karim Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15317442. The registered office is 12 CLAUDIA JONES WAY, LONDON, SW2 5PP.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.